Listeriosis is an infection caused by the bacteria Listeria monocytogenes. Listeria monocytogenes, the cause of the condition, can lead to fatal infections in young children, frail or elderly people, and others with weakened immune systems. Currently there is no specific treatment available for the condition. Consuming contaminated food can increase the risk of listeriosis. Infection with listeria Monocytogenes results in mild to severe gastroenteritis and can lead to meningitis and septicemia. The condition can also increase the risk of diabetes, HIV, cancer, chronic liver, and kidney disease. Symptoms of the disease include, high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea.
For Requesting a Sample Copy of This Report, Please Visit @
R&D in listeriosis is expected to propel growth of the global listeria monocytogenes infections treatment market over the forecast period. For instance, in May 2017, a study from the University of Southern Denmark reported that omega-3 fatty acids can help to deactivate the genes in listeria monocytogenes, thereby offering potential treatment for listeria monocytogenes.
Outbreak of listeria infection is also expected to aid in growth of the market. For instance, in 2017, retailers in the U.S. recalled raw milk cheeses made by Vulto Creamery after outbreak of listeria infection.
Development of new therapeutic approach for the treatment of listeria monocytogenes is expected to offer lucrative growth opportunities for players in the global listeria monocytogenes infections treatment market. For instance, in October, 2017, the U.S. Food and Drug Administration suggested R&D of new therapeutic approach for the treatment of listeria monocytogenes infection to address outbreak of the condition in the U.S.
Increasing consumption of fast food is expected to increase the risk of listeria monocytogenes infections. For instance, in May, 2017, the Centers for Disease Control and Prevention suggested to avoid fast food. In September 2021, Baker Farms announced to recall its Baker Farms, Kroger & SEG Grocers brand names of Kale due to contamination of Listeria monocytogenes.
Request a PDF Brochure with Latest Insights @
North America is expected to witness significant growth in the global listeria monocytogenes infections treatment market, owing to high incidence of listeria. For instance, listeria is the third leading cause of death in the U.S. and around 1,600 people suffer from listeria every year, according to the Centers for Disease Control and Prevention. Moreover, approximately 0.24 new cases per 100,000 were reported in 2015 in the U.S.
Europe is also expected to witness significant growth in the global listeria monocytogenes infections treatment market, owing to high incidence of listeria. For instance, around 180 cases of listeriosis were reported in 2014, among which around 87% were non-pregnancy associated and 12.4% were pregnancy associated listeriosis, according to the Public Health England.
Major players operating in the global listeria monocytogenes infections treatment market include, Astellas Pharma, Inc., Abbott Laboratories, Bristol Myers Squibb Company, Bayer AG, Eli Lilly and Company, GlaxoSmithKline plc, Janssen Pharmaceuticals, Novartis AG, Pfizer, Inc., and Sanofi.
Reasons to Purchase this Report
• Current and future of global Listeria Monocytogenes Infections Treatment market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Content
Global Listeria Monocytogenes Infections Treatment Market Research Report
Section 1: Global Listeria Monocytogenes Infections Treatment Industry Overview
Section 2: Global Economic Impact on Listeria Monocytogenes Infections Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Listeria Monocytogenes Infections Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027